Arkolith/Insider Trading/LYRA/Form 4

Merrifield C Ann

DirectorLyra Therapeutics, Inc. (LYRA) · full profile →Form 4 · filed Jun 13, 2022
Net Buying
Open-Market Buys
$20K
Open-Market Sells
$0
Net Open-Market Flow
$20K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 10, 2022Buy(P)4K$5.05$20K11K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-022154) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML